Thursday, January 28, 2021
Researchers in the neuroscience field utilize EEG for experiments in real-world and simulated environments. EEG systems can often be uncomfortable for participants and difficult to set up for researchers. The B-Alert X Series in combination with BIOPAC’s data collection systems make it much easier for researchers who do work in EEG-based metrics, Brain-Computer Interfaces (BCI), Consumer Neuroscience, Team Neurodynamics, Human Performance, Fatigue Management, etc. Participants are much more comfortable in this type of system, ensuring the best outcome for data quality.
Join us with Chris Berka, CEO and Co-Founder of Advanced Brain Monitoring, and Frazer Findlay, CEO of BIOPAC Systems, to learn how B-Alert X24 allows researchers to quickly collect 20 channels of EEG data to provide more information from the brain and target more regions with better resolution.
Attend this workshop to:
B-Alert X-Series Systems offer acquisition of high-fidelity wireless EEG plus ECG, and AcqKnowledge adds powerful analysis tools, including automated scoring and reporting options.
This webinar applies to:
Related B-Alert Webinars:
Complete Form to Watch Webinar!
About Chris Berka
Chris Berka, CEO and Co-Founder of Advanced Brain Monitoring has over 30 years of experience managing clinical research and developing and commercializing new technologies. She is co-inventor of more than 20 patented and PI or Co-Investigator for grants awarded by the National Institutes of Health, DARPA, ONR, OSD, and NSF that provided more than $37 million of research funds to ABM. As CEO of ABM, she leads the research team in projects designed to advance the design, implementation, and validation of novel EEG-based approaches for assessment of neural activity during sleep and waking. Novel empirically and theoretically derived algorithms are featured in her publications on assessing cognition in healthy participants in laboratory and real-world environments and in patients with sleep, psychiatric and neurological diseases. She is an experienced neuroscientist with over 100 publications on the analysis of the EEG correlates of cognition in healthy subjects and patients with sleep and neurological disorders.
Frazer Findlay is CEO of BIOPAC and has more than 25 years’ experience in life science data acquisition and analysis. Frazer is a well-regarded expert in the physiology monitoring industry and has facilitated workshops in the U.S., Europe, and Asia. He is familiar with a variety of software, equipment, and laboratory protocols for a wide array of signals and measurements. Frazer joined BIOPAC in 1996 when he moved from the UK to Santa Barbara as Domestic Sales Manager. He became CEO in 2008 and has continued to develop and grow the business while also working with physiology measurement and biometric companies to improve the physiology monitoring industry.